Science Corporation implants its vision-restoring chip in its first Stargardt disease patient; Max Hodak discusses PRIMA’s path toward a novel brain-computer interface at TechCrunch Disrupt
Read the original at techcrunch.com→Max Hodak, the former president and co-founder of Neuralink, detailed on stage at TechCrunch Disrupt how his company's work with PRIMA is part of its path toward a novel brain-computer interface (BCI).
Original headline: "Science Corporation implants its vision-restoring chip in its first Stargardt disease patient"
Coverage timeline
- Oct 13, 23:13 UTC TechCrunch AI lead source Science Corporation implants its vision-restoring chip in its first Stargardt disease patient